Medical Simulator
Medical Simulator is an educational platform for basic and advanced training of cardiovascular procedures. We primarily target novice learners such as medical students and early phase residents in cardiology, cardiothoracic, cardiovascular or (interventional) radiology. However, the platform will also offer advanced modules aimed at experienced surgeons or interventionists who would like to practice the steps prior to performing complex, high-risk procedures. The platform will be developed as an extended reality (XR) application; our goal is to replace the traditional approach of ‘observe one, do one, teach one’ with ‘observe one, simulate many, then do one’.
Medical Simulator aims to transform the current way of learning and practice of surgical techniques in the field of cardiovascular surgery and will represent an innovative platform that will cover these modules and pathologies.
The team consist of eminent regional and European doctors, including a surgeon from the Erasmus MC Cardiothoracic department in Rotterdam, the Netherlands.
Our Medical Simulator will close the gap between theoretical knowledge and practice. With the support of this project, FITR supports creation of an innovative platform, based on the revolutionary concept of VR and indirectly helps advance clinical practice.
Precise Pharmacy
Have you ever wondered why a medicine did not work for you when it worked for someone else? Or why do some people experience side effects as a result of medication therapy, while others do not?
Perhaps you have noticed that a certain dose of a medicine works for some patients, whereas others see no effect. Through this project, Distant Point aims at making pharmacotherapy more precise by being personalized (customized) for each patient individually with the patient’s pharmacogenetic 1 profile and information about drug-drug interaction.
For this purpose, this project with the help of a partner laboratory will include the development of genetic tests which will enable determination of the full pharmacogenetic profile of the patient using NGS and real time PCR technologies. Furthermore, the genetic data will be processed into a software platform that will be specially developed as part of this project and which will aim to interpret the genetic information of each individual patient, derived from the in house developed genetic tests, while taking into account the general information about drug- drug interaction that the patient takes or should take. With such a comprehensive and detailed evaluation, the doctor or pharmacist will gain information on the best therapy for each patient individually, in an individualized and precise manner. In addition, the entire pharmacogenetics ID (passport) of the patient will be stored into the software. This is done once in a lifetime.
